Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAx6t2VGzXNdaSHysTx1kBRR3ZBpazJFMj9qXiLCvCANk#assertion>. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "oseltamivir phosphate for oral suspension is an influenza neuraminidase inhibitor nai indicated for treatment of acute uncomplicated influenza a and b in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours 1 1 prophylaxis of influenza a and b in patients 1 year and older 1 2 limitations of use not a substitute for annual influenza vaccination 1 3 consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use 1 3 not recommended for patients with end stage renal disease not undergoing dialysis 1 3 oseltamivir phosphate for oral suspension is indicated for the treatment of acute uncomplicated illness due to influenza a and b infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours oseltamivir phosphate for oral suspension is indicated for the prophylaxis of influenza a and b in patients 1 year and older oseltamivir phosphate for oral suspension is not a substitute for early influenza vaccination on an annual basis as recommended by the centers for disease control and prevention advisory committee on immunization practices influenza viruses change over time emergence of resistance substitutions could decrease drug effectiveness other factors for example changes in viral virulence might also diminish clinical benefit of antiviral drugs prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use oseltamivir phosphate for oral suspension see microbiology 12 4 oseltamivir phosphate for oral suspension is not recommended for patients with end stage renal disease not undergoing dialysis see dosage and administration 2 4 use in specific populations 8 6" assertion.
- association subject drugbank:DB02600 assertion.
- association predicate treats assertion.
- association object DOID_8469 assertion.
- association relation TreatmentIndication assertion.
- drugbank:DB02600 category Drug assertion.
- DOID_8469 category Disease assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- association provided_by NeuroDKG assertion.